×
It looks like you're using an obsolete version of internet explorer. Internet explorer is no longer supported by Microsoft since the end of 2015. We invite you to use a newer browser such as Firefox, Google Chrome or Microsoft Edge.

Become an Oncostream member and receive full access to its content!

You must be an Oncostream member to access videos without any restrictions. Register for free in one minute and access all services provided by Oncostream.You will also be able to log into Oncostream from your Facebook or twitter account by clicking on login on the top-right corner of Oncostream website.

Registration Login


Worldwide schedules comment Share

Modérateur :
Pr Florence Joly

Orateurs :
Dr Margaux Renier
Pr Florence Joly
Dr Paule Augereau

Épisode 1 : Découvrez le programme

 

13:00 Introduction
 
13:02 Cas clinique : Carcinose péritonéale endomètre dMMR
Margaux Renier
 
13:12 Quel traitement aujourd'hui ? place IO en association ?
Florence Joly & Paule Augereau
 
13:22 Place IO seule ou des schémas sans chimio ?
Florence Joly & Paule Augereau
 
13:32 En cas de réponse exceptionnelle, y a t-il encore une place pour la chirurgie ?
Florence Joly & Paule Augereau
 
13:42 Débat/Discussion et réponses aux questions
Florence Joly & Paule Augereau
 

Ne manquez pas les prochaines sessions sur la prise en charge du cancer de l'endomètre avancé !

Épisode 2 Cancer de l'endomètre avancé en rechute précoce :que proposer en 2025
RDV le 26 mars 2025 13h
 
Épisode 3 Cancer de l'endomètre avancé pMMR P53 muté
RDV le 9 avril 2025 13h
 
Épisode 4 Cancer de l'endomètre avancé pMMR NSMP
RDV le 29 avril 2025 13h
 

 

Shooting date : 2025-03-12
Last update : 2025-05-19

Suggestions

Tuesday, July 1st 2025 from 01pm to 01:45pm (GMT+2)
Honolulu : Tuesday, July 1st 2025 from 01am to 01:45am (GMT+2)
San Francisco : Tuesday, July 1st 2025 from 04am to 04:45am (GMT+2)
New York : Tuesday, July 1st 2025 from 07am to 07:45am (GMT+2)
Buenos Aires : Tuesday, July 1st 2025 from 08am to 08:45am (GMT+2)
Reykjavik : Tuesday, July 1st 2025 from 11am to 11:45am (GMT+2)
London / Dublin : Tuesday, July 1st 2025 from 12pm to 12:45pm (GMT+2)
Paris / Berlin : Tuesday, July 1st 2025 from 01pm to 01:45pm (GMT+2)
Istanbul : Tuesday, July 1st 2025 from 02pm to 02:45pm (GMT+2)
Moscou / Dubaï : Tuesday, July 1st 2025 from 03pm to 03:45pm (GMT+2)
Bangkok : Tuesday, July 1st 2025 from 06pm to 06:45pm (GMT+2)
Shanghai : Tuesday, July 1st 2025 from 07pm to 07:45pm (GMT+2)
Tokyo : Tuesday, July 1st 2025 from 08pm to 08:45pm (GMT+2)
Sydney : Tuesday, July 1st 2025 from 10pm to 10:45pm (GMT+2)
Wellington : Wednesday, July 2nd 2025 from 12am to 12:45am (GMT+2)

Quels changements de pratique dans le cancer de l’ovaire en 1L après le congrès américain ?

Share
0
Days
0
Hours
0
Minutes
0
Seconds
Monday, September 22nd 2025 from 01pm to 01:45pm (GMT+2)
Honolulu : Monday, September 22nd 2025 from 01am to 01:45am (GMT+2)
San Francisco : Monday, September 22nd 2025 from 04am to 04:45am (GMT+2)
New York : Monday, September 22nd 2025 from 07am to 07:45am (GMT+2)
Buenos Aires : Monday, September 22nd 2025 from 08am to 08:45am (GMT+2)
Reykjavik : Monday, September 22nd 2025 from 11am to 11:45am (GMT+2)
London / Dublin : Monday, September 22nd 2025 from 12pm to 12:45pm (GMT+2)
Paris / Berlin : Monday, September 22nd 2025 from 01pm to 01:45pm (GMT+2)
Istanbul : Monday, September 22nd 2025 from 02pm to 02:45pm (GMT+2)
Moscou / Dubaï : Monday, September 22nd 2025 from 03pm to 03:45pm (GMT+2)
Bangkok : Monday, September 22nd 2025 from 06pm to 06:45pm (GMT+2)
Shanghai : Monday, September 22nd 2025 from 07pm to 07:45pm (GMT+2)
Tokyo : Monday, September 22nd 2025 from 08pm to 08:45pm (GMT+2)
Sydney : Monday, September 22nd 2025 from 10pm to 10:45pm (GMT+2)
Wellington : Tuesday, September 23rd 2025 from 12am to 12:45am (GMT+2)

Présentation des recommandations de SPV Ovaire sur le traitement de maintenance

Tuesday, September 5th 2023 from 06:30pm to 08pm (GMT+2)
Honolulu : Tuesday, September 5th 2023 from 06:30am to 08am (GMT+2)
San Francisco : Tuesday, September 5th 2023 from 09:30am to 11am (GMT+2)
New York : Tuesday, September 5th 2023 from 12:30pm to 02pm (GMT+2)
Buenos Aires : Tuesday, September 5th 2023 from 01:30pm to 03pm (GMT+2)
Reykjavik : Tuesday, September 5th 2023 from 04:30pm to 06pm (GMT+2)
London / Dublin : Tuesday, September 5th 2023 from 05:30pm to 07pm (GMT+2)
Paris / Berlin : Tuesday, September 5th 2023 from 06:30pm to 08pm (GMT+2)
Istanbul : Tuesday, September 5th 2023 from 07:30pm to 09pm (GMT+2)
Moscou / Dubaï : Tuesday, September 5th 2023 from 08:30pm to 10pm (GMT+2)
Bangkok : Tuesday, September 5th 2023 from 11:30pm to 01am (GMT+2)
Shanghai : Wednesday, September 6th 2023 from 12:30am to 02am (GMT+2)
Tokyo : Wednesday, September 6th 2023 from 01:30am to 03am (GMT+2)
Sydney : Wednesday, September 6th 2023 from 03:30am to 05am (GMT+2)
Wellington : Wednesday, September 6th 2023 from 05:30am to 07am (GMT+2)

Les nouveaux enjeux de la prise en charge du cancer de l’ovaire en première ligne : L’exemple d...

Cycle d'enseignement sur le cancer de l'ovaire - Première session

Share
Wednesday, February 7th 2024 from 06pm to 07:30pm (GMT+1)
Honolulu : Wednesday, February 7th 2024 from 06am to 07:30am (GMT+1)
San Francisco : Wednesday, February 7th 2024 from 08am to 09:30am (GMT+1)
New York : Wednesday, February 7th 2024 from 11am to 12:30pm (GMT+1)
Buenos Aires : Wednesday, February 7th 2024 from 01pm to 02:30pm (GMT+1)
London / Dublin : Wednesday, February 7th 2024 from 04pm to 05:30pm (GMT+1)
Paris / Berlin : Wednesday, February 7th 2024 from 05pm to 06:30pm (GMT+1)
Istanbul : Wednesday, February 7th 2024 from 06pm to 07:30pm (GMT+1)
Moscou / Dubaï : Wednesday, February 7th 2024 from 08pm to 09:30pm (GMT+1)
Bangkok : Wednesday, February 7th 2024 from 11pm to 12:30am (GMT+1)
Shanghai : Thursday, February 8th 2024 from 12am to 01:30am (GMT+1)
Tokyo : Thursday, February 8th 2024 from 01am to 02:30am (GMT+1)
Sydney : Thursday, February 8th 2024 from 02am to 03:30am (GMT+1)
Wellington : Thursday, February 8th 2024 from 04am to 05:30am (GMT+1)

Toxicités hématologiques des inhibiteurs de PARP

Regards croisés oncologue-hématologue-interniste

Share
Scroll Up